Sonoma Pharmaceuticals SNOA
NASDAQ SNOA
$1.34 -0.02 (-1.48%)
At close: Aug 20, 2026 · 1:40 PM UTC

Sonoma Pharmaceuticals (SNOA) Divestments (2015 - 2020)

Sonoma Pharmaceuticals (SNOA) posted quarterly Divestments of $610000.0 for Q2 2020, down 86.56% quarter-over-quarter from $4.5 million in Q2 2015.

Sonoma Pharmaceuticals (SNOA) Divestments (2015 - 2020) Analysis & Trends

Sonoma Pharmaceuticals' Divestments history runs 2 years deep, the most recent figure standing at $610000.0 for Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Haleon 43.91 Bn 42.95 Bn - -
2 Teva Pharmaceutical Industries 42.98 Bn 39.32 Bn 2.15 Bn 4.00 Mn
3 Zoetis 31.53 Bn 29.86 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn 65.64 Mn
5 United Therapeutics 22.16 Bn 19.49 Bn 683.80 Mn -
6 Viatris 18.74 Bn 17.85 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.51 Bn 15.12 Bn 935.80 Mn -
8 Elanco Animal Health 11.76 Bn 11.23 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.12 Bn 9.95 Bn - -
10 Sonoma Pharmaceuticals 5.15 Mn -184,359.87 2.58 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2020 610,000.00
Jun 30, 2015 4.54 Mn